Literature DB >> 21103946

Neuroimmune pharmacology as a sub-discipline of medical neuroscience in the medical school curriculum.

Robert W Freilich1, Tsuneya Ikezu.   

Abstract

The emerging field of neuroimmune pharmacology (NIP) is the confluence of three distinct disciplines: neuroscience, immunology, and pharmacology (Gendelman and Ikezu 2008). NIP was born from the realization that inflammation within the central nervous system (CNS) plays a crucial role in many neurological pathologies and as such offers a rich array of novel pharmacological targets as potential therapeutics. As this field is likely to have a major impact in medical science, educating future physicians on this area will help increase awareness and may potentially inspire them to pursue careers in the field of NIP. However, a key challenge for medical educators, is how best to incorporate new material on emerging fields, such as NIP, into the medical school curriculum, specifically in the context of a medical neuroscience course. We propose the addition of two 50-min lectures plus an additional optional 2-h lab module to the standard first year medical neuroscience class curriculum. Lecture 1 will focus on how the CNS and the immune system inter-communicate with one another with emphasis on neuroanatomical features and chemical signal transduction between the two systems. Lecture 2 provides an introduction to inflammation in the CNS and provides a series of clinical correlates to describe how CNS inflammation contributes to the disease process. The lab module provides detailed visual examples of how CNS inflammation influences disease processes and provides two examples of how application of an immunomodulatory pharmacological agent can modify disease processes.

Entities:  

Mesh:

Year:  2010        PMID: 21103946      PMCID: PMC3101078          DOI: 10.1007/s11481-010-9250-7

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  40 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

2.  What is the blood-brain barrier (not)?

Authors:  Ingo Bechmann; Ian Galea; V Hugh Perry
Journal:  Trends Immunol       Date:  2006-11-30       Impact factor: 16.687

3.  CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.

Authors:  Marcus Müller; Sally L Carter; Markus J Hofer; Peter Manders; Daniel R Getts; Meghan T Getts; Angela Dreykluft; Bao Lu; Craig Gerard; Nicholas J C King; Iain L Campbell
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

Review 4.  The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid.

Authors:  Esteban M Rodríguez; Juan L Blázquez; Montserrat Guerra
Journal:  Peptides       Date:  2010-01-20       Impact factor: 3.750

5.  Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS.

Authors:  Derek D C Ireland; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

6.  Randomized, controlled trial of spaced education to urology residents in the United States and Canada.

Authors:  B Price Kerfoot; Harley E Baker; Michael O Koch; Donna Connelly; David B Joseph; Michael L Ritchey
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

Review 7.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

8.  Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat.

Authors:  Omar M E Abdel-Salam; Salwa M Nofal; Siham M El-Shenawy
Journal:  Pharmacol Res       Date:  2003-08       Impact factor: 7.658

Review 9.  The blood-brain barrier in neurodegenerative disease: a rhetorical perspective.

Authors:  Paul M Carvey; Bill Hendey; Angela J Monahan
Journal:  J Neurochem       Date:  2009-07-31       Impact factor: 5.372

10.  Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Authors:  J Sanchez-Ramos; S Song; V Sava; B Catlow; X Lin; T Mori; C Cao; G W Arendash
Journal:  Neuroscience       Date:  2009-06-14       Impact factor: 3.590

View more
  1 in total

1.  Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia.

Authors:  Robert W Freilich; Maya E Woodbury; Tsuneya Ikezu
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.